NASDAQ:AKUMQ Akumin (AKUMQ) Stock Price, News & Analysis → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free AKUMQ Stock Alerts $0.38 -0.03 (-6.25%) (As of 02/6/2024) Add Compare Share Share Today's Range$0.38▼$0.3850-Day Range$0.38▼$0.3852-Week Range$0.12▼$1.43Volume1,000 shsAverage Volume196,980 shsMarket Capitalization$34.19 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsSEC FilingsSocial MediaStock AnalysisChartEarningsFinancialsSEC FilingsSocial Media Get Akumin alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Akumin Stock (NASDAQ:AKUMQ)Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other diagnostic and interventional radiology procedures through owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to hospitals and health systems across 48 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida. On October 22, 2023, Akumin Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.Read More AKUMQ Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AKUMQ Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive AKUMQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Akumin and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/27/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryN/A Current SymbolNASDAQ:AKUMQ Previous SymbolNASDAQ:AKUMQ CUSIPN/A CIK1776197 Webwww.akumin.com Phone844-730-0050FaxN/AEmployees3,631Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.82) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-156,760,000.00 Net Margins-34.67% Pretax Margin-35.23% Return on Equity-1,249.92% Return on Assets-8.42% Debt Debt-to-Equity RatioN/A Current Ratio0.12 Quick Ratio0.12 Sales & Book Value Annual Sales$749.63 million Price / Sales0.05 Cash FlowN/A Price / Cash FlowN/A Book Value$1.24 per share Price / Book0.30Miscellaneous Outstanding Shares91,170,000Free Float72,473,000Market Cap$34.19 million OptionableNot Optionable Beta-1.02 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Riadh Zine-El-Abidine (Age 52)Chairman & CEO Comp: $1.78MMr. Krishna Kumar AnanthasubramanianPresident & COOMr. Ronald J. Bienias (Age 52)Interim CFO & Chief Restructuring Officer Mr. Paul Nelis (Age 56)Chief Information Officer Darren SpeedChief Compliance OfficerMs. Tracy Wiese (Age 55)Chief Strategy & Marketing Officer Ms. Holly Huso (Age 59)Enterprise Sales Officer Ms. Laurie R. Miller (Age 57)Chief Human Resources Officer Mr. Mohammad SaleemSenior Vice President of Financial ReportingMr. Christopher FitzgeraldChief Revenue OfficerMore ExecutivesKey CompetitorsExagenNASDAQ:XGNDermTechNASDAQ:DMTKPsychemedicsNASDAQ:PMDEnzo BiochemNYSE:ENZCentogeneNASDAQ:CNTGView All Competitors AKUMQ Stock Analysis - Frequently Asked Questions How have AKUMQ shares performed in 2024? Akumin's stock was trading at $0.3328 at the beginning of the year. Since then, AKUMQ shares have increased by 12.7% and is now trading at $0.3750. View the best growth stocks for 2024 here. How do I buy shares of Akumin? Shares of AKUMQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:AKUMQ) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akumin Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
